Increased PD-1+ cells in tumor biopsies have been associated with either favorable prognosis in patients with follicular lymphoma (31, 32), lung cancer (33), ovarian cancer (34), or poor survival in cancer patients (35, 36). The gene discussed is PDCD1; the disease is neoplasm.